Dr. Reddy's Laboratories Ltd.
DRREDDY · NSE · Healthcare · ₹1,203 a share (close of 05 Oct 2026)
Available company data, source links and archived checks for Dr. Reddy's Laboratories Ltd.. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Revenue fell 5.5%; Net profit was ₹435.60 crore.
Quarter ended 2026-06-30 · consolidated · Company filing
📅 Next event: board meeting — quarterly results — Fri 23 Oct. Filed with the exchange; the desks read the outcome that night.
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Jun 2026 | Revenue: ₹8,100 cr | -5.5% | Net profit: ₹436 cr | -69.1% | 5.4% | Company filing source |
| Mar 2026 | Revenue: ₹7,546 cr | -11.5% | Net profit: ₹221 cr | -86.1% | 2.9% | Company filing source |
| Dec 2025 | Revenue: ₹8,753 cr | — | Net profit: ₹1,190 cr | — | 13.6% | Company filing source |
| Sep 2025 | Revenue: ₹8,828 cr | — | Net profit: ₹1,337 cr | — | 15.1% | Company filing source |
| Jun 2025 | Revenue: ₹8,572 cr | +11.4% | Net profit: ₹1,410 cr | +1.3% | 16.4% | Company filing source |
| Mar 2025 | Revenue: ₹8,528 cr | — | Net profit: ₹1,587 cr | — | 18.6% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
LIFE INSURANCE CORPORATION OF INDIA P & GS FUND 12.2%GVP Family Trust 11.5%J P Morgan Chase Bank NA 11.4%VSD Family Trust 9.1%ICICI PRUDENTIAL VALUE DISCOVERY FUND 4.4%register as filed
2026-06-30
Filing timeline — what the company told the exchange
- Action(s) taken or orders passed. Dr. Reddy's Laboratories Limited has informed the Exchange about imposition of penalty to Dr. Reddy s Laboratories, Inc. ( DRL…
03 Oct 2026 · document
- Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2…
22 Sep 2026 · document
- Analysts/Institutional Investor Meet/Con. Call Updates. Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet…
21 Sep 2026 · document
- Arrangements for strategic, technical, manufacturing, or marketing tie up. Dr. Reddy's Laboratories Limited has today, i.e., September 18, 2026, entered into an…
18 Sep 2026 · document
- News Verification. The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Dr Reddy s gets volunt…
18 Sep 2026 · document
- News Verification. The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Dr Reddy s gets volunt…
17 Sep 2026 · document
- Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication…
16 Sep 2026 · document
- Dr. Reddy's Laboratories Limited has informed the Exchange about General Updates…
11 Sep 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time